GGrantIndex
← Leaderboards

Lee A. Hebert

Ohio State University

$3,485,580
Attributed
$3,485,580
Total exposure
11
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.5M · FY200508
$2M$1.5M$1M$500K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$8,385,422 · 12

By mechanism

P01$5,491,626 · 3
U01$1,548,606 · 1
M01$1,345,190 · 8

Top collaborators

No co-investigators on record.

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectNephritisDisease /Disorder Proneness /RiskAfrican AmericanPathologic ProcessClinical ResearchPatient Oriented ResearchAce InhibitorsSystemic Lupus ErythematosusLongitudinal Human StudyGenetic SusceptibilityAntihypertensive AgentsBlood PressureCooperative StudyClinical TrialsHuman Therapy EvaluationChemokineCalcium Channel BlockersInfectionStressKidneyFollow-UpEchocardiographyGenetic

Grant awards (34)

GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS$1,039
M01 · FY2008 · RR · contact PI
Genetic & Clinical Risk for Human SLE Nephritis$143,104
P01 · FY2007 · DK · contact PI
AASK Cohort Study$41,412
U01 · FY2007 · DK · contact PI
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS$3,082
M01 · FY2007 · RR · contact PI
OHIO SLE STUDY LONGITUDINAL STUDY$194,080
M01 · FY2006 · RR · contact PI
AASK Cohort Study$159,993
U01 · FY2006 · DK · contact PI
Genetic & Clinical Risk for Human SLE Nephritis$112,500
P01 · FY2006 · DK · contact PI
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS$3,081
M01 · FY2006 · RR · contact PI
Genetic &Clinical Risk for Human SLE Nephritis$974,620
P01 · FY2005 · DK
OHIO SLE STUDY LONGITUDINAL STUDY$301,129
M01 · FY2005 · RR
AASK Cohort Study$163,297
U01 · FY2005 · DK
GENETIC AND CLINICAL RISK FACTORS FOR HUMAN SLE NEPHRITIS$93,373
M01 · FY2005 · RR
Genetic &Clinical Risk for Human SLE Nephritis$950,223
P01 · FY2004 · DK
Ohio SLE Study Longitudinal Study$276,113
M01 · FY2004 · RR
Genetic &clinical risk factors for human SLE nephritis$230,799
M01 · FY2004 · RR
AASK Cohort Study$163,297
U01 · FY2004 · DK
AASK Cohort Study$4,425
U01 · FY2004 · DK
Genetic &Clinical Risk for Human SLE Nephritis$929,424
P01 · FY2003 · DK
AASK Cohort Study$163,297
U01 · FY2003 · DK
AASK Cohort Study$4,425
U01 · FY2003 · DK
Genetic &Clinical Risk for Human SLE Nephritis$897,911
P01 · FY2002 · DK
Pathogenesis of SLE relapse in humans$295,892
P01 · FY2002 · DK
Core--Coordination$295,892
P01 · FY2002 · DK
OHIO STATE UNIVERSITY APPLICATION TO AASK$155,248
U01 · FY2002 · DK
Genetic &Clinical Risk for Human SLE Nephritis$892,060
P01 · FY2001 · DK
OHIO STATE UNIVERSITY APPLICATION TO AASK$356,327
U01 · FY2001 · DK
GENETIC ANOMALIES OF C4, CR1 &FCYR JUVENILE IGA NEPHRITIS$193,916
M01 · FY2001 · RR
Pathogenesis of SLE relapse in humans$0
P01 · FY2001 · DK
Core--Coordination$0
P01 · FY2001 · DK
OHIO STATE UNIVERSITY APPLICATION TO AASK$336,885
U01 · FY2000 · DK
GENETIC ANOMALIES OF C4, CR1 &FCYR JUVENILE IGA NEPHRITIS$48,578
M01 · FY2000 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION$0
M01 · FY2000 · RR
AFRICAN AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION$0
M01 · FY2000 · RR
GENETIC ANOMALIES OF C4, CR1 &FCYR JUVENILE IGA NEPHRITIS$0
M01 · FY2000 · RR